Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Apollo Medical Holdings, Inc. (AMEH)
|
Add to portfolio |
|
|
|
| Price: |
$65.34
| | Metrics |
| OS: |
57.6
|
M
| |
8
|
% ROE
|
| Market cap: |
$3.76
|
B
| |
27
|
% ROIC
|
|
Net cash:
|
$89.9
|
M
| |
$1.56
|
per share
|
|
EV:
|
$3.67
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$137
|
M
| |
26.7
|
x EV/EBITDA
|
|
EBIT
|
$120
|
M
| |
30.6
|
x EV/EBIT
|
| EPS |
$0.98
| |
66.5
|
x P/E
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Mar-31-17 | Dec-31-16 |
| Revenues | 1,144.2 | 773.9 | 687.2 | 560.6 | 519.9 | 356.4 | 57.4 | 305.9 |
| Revenue growth | 47.8% | 12.6% | 22.6% | 7.8% | 45.9% | 16.5% | 30.4% | |
| Cost of goods sold | 962.2 | 613.7 | 557.6 | 467.8 | 361.1 | 273.5 | 48.7 | 254.8 |
| Gross profit | 181.9 | 160.3 | 129.6 | 92.8 | 158.8 | 82.9 | 8.7 | 51.2 |
| Gross margin | 15.9% | 20.7% | 18.9% | 16.6% | 30.5% | 23.3% | 15.1% | 16.7% |
| General and administrative | 77.7 | 62.1 | 49.1 | 41.5 | 43.4 | 26.2 | 18.6 | 21.0 |
| EBITA | 123.6 | 109.3 | 100.2 | 43.8 | 101.2 | 54.9 | -10.2 | 16.8 |
| EBITA margin | 10.8% | 14.1% | 14.6% | 7.8% | 19.5% | 15.4% | -17.8% | 5.5% |
| Amortization of intangibles | 13.7 | 15.4 | 16.0 | 16.3 | 17.1 | 17.5 | 0.0 | |
| EBIT | 109.9 | 93.9 | 84.2 | 27.5 | 84.1 | 37.4 | -10.3 | 16.8 |
| EBIT margin | 9.6% | 12.1% | 12.3% | 4.9% | 16.2% | 10.5% | -17.9% | 5.5% |
| Pre-tax income | 86.6 | 77.7 | 178.4 | 25.8 | 82.6 | 49.7 | -8.7 | 18.8 |
| Income taxes | 40.9 | 31.7 | 56.3 | 8.2 | 22.4 | 3.9 | 0.0 | 8.8 |
| Tax rate | 47.2% | 40.8% | 31.6% | 31.6% | 27.1% | 7.8% | 0.5% | 46.8% |
| Net income | 45.2 | 68.9 | 37.7 | 14.1 | 10.8 | 25.8 | -9.0 | 11.5 |
| Net margin | 3.9% | 8.9% | 5.5% | 2.5% | 2.1% | 7.2% | -15.6% | 3.7% |
| |
| Diluted EPS | $0.99 | $1.52 | $1.01 | $0.39 | $0.29 | $0.90 | ($1.49) | $0.41 |
| Shares outstanding (diluted) | 45.6 | 45.4 | 37.4 | 36.4 | 37.9 | 28.7 | 6.0 | 28.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|